Results 41 to 50 of about 4,565,322 (357)

A Decade of Disparities in Diabetes Technology Use and HbA1c in Pediatric Type 1 Diabetes: A Transatlantic Comparison

open access: yesDiabetes Care, 2020
OBJECTIVE As diabetes technology use in youth increases worldwide, inequalities in access may exacerbate disparities in hemoglobin A1c (HbA1c). We hypothesized that an increasing gap in diabetes technology use by socioeconomic status (SES) would be ...
Ananta Addala   +9 more
semanticscholar   +1 more source

Important Drop in Rate of Acute Diabetes Complications in People With Type 1 or Type 2 Diabetes After Initiation of Flash Glucose Monitoring in France: The RELIEF Study

open access: yesDiabetes Care, 2021
OBJECTIVE The RELIEF study assessed rates of hospitalization for acute diabetes complications in France before and after initiation of the FreeStyle Libre system.
R. Roussel   +7 more
semanticscholar   +1 more source

Neutrophils in type 1 diabetes [PDF]

open access: yesJournal of Diabetes Investigation, 2016
AbstractType 1 diabetes is an autoimmune disease that afflicts millions of people worldwide. It occurs as the consequence of destruction of insulin‐producing pancreatic β‐cells triggered by genetic and environmental factors. The initiation and progression of the disease involves a complicated interaction between β‐cells and immune cells of both innate ...
Juan Huang   +3 more
openaire   +2 more sources

Type 1 diabetes vaccine candidates promote human Foxp3+Treg induction in humanized mice

open access: yesNature Communications, 2016
Type 1 diabetes is associated with the loss of self-tolerance to the insulin-producing β-cells in the pancreas. Here the authors show that vaccination with insulin mimetopes can induce human insulin-specific regulatory T cells to mediate tolerance in a ...
Isabelle Serr   +11 more
doaj   +1 more source

A quantitative measure of treatment response in recent‐onset type 1 diabetes

open access: yesEndocrinology, Diabetes & Metabolism, 2020
Introduction This paper develops a methodology and defines a measure that can be used to separate subjects that received an experimental therapy into those that benefitted from those that did not in recent‐onset type 1 diabetes.
Brian N. Bundy   +2 more
doaj   +1 more source

Low-grade inflammation in type 2 diabetes: a cross-sectional study from a Danish diabetes outpatient clinic

open access: yesBMJ Open, 2022
Objectives To investigate low-grade inflammation in type 2 diabetes and explore associations to clinical aspects as well as microvascular and macrovascular complications.Design Cross-sectional analysis.Setting The outpatient diabetes clinic at the ...
Joachim Størling   +5 more
doaj   +1 more source

Has COVID-19 Delayed the Diagnosis and Worsened the Presentation of Type 1 Diabetes in Children?

open access: yesDiabetes Care, 2020
OBJECTIVE To evaluate whether the diagnosis of pediatric type 1 diabetes or its acute complications changed during the early phase of the coronavirus disease 2019 (COVID-19) pandemic in Italy.
I. Rabbone   +4 more
semanticscholar   +1 more source

Primary understanding of type 1 diabetes as an autoimmune disease

open access: yesSaudi Journal for Health Sciences, 2022
Type 1 diabetes (T1D) is classified as an autoimmune disease affecting a wide range of people worldwide. Beta cells in the pancreatic islets of Langerhans in the pancreases are responsible for insulin productions, which help in the exchange of blood ...
Mohamd A Alblihed
doaj   +1 more source

Does Type 1 Diabetes Affect Male Infertility: Type 1 Diabetes Exchange Registry-Based Analysis

open access: yesSociété Internationale d’Urologie Journal, 2021
IntroductionThe prevalence of type 1 diabetes (T1D) has been increasing over the last few decades and is commonly believed to negatively impact male fertility.
Omer A. Raheem, Marah C. Hehemann, Marc J. Rogers, Judy N. Fustok, Irl B. Hirsch, Thomas J. Walsh
doaj   +1 more source

Hypoglycemia in Type 1 Diabetes [PDF]

open access: yesDiabetes, 2010
In subjects with type 1 diabetes, autoimmune destruction of pancreatic β-cells leads eventually to an absolute requirement for insulin replacement therapy. Insulin delivered exogenously is not subject to normal physiological feedback regulation, so it may induce hypoglycemia even in the presence of an intact counterregulatory response.
McCrimmon, Rory J., Sherwin, Robert S.
openaire   +3 more sources

Home - About - Disclaimer - Privacy